Skip to main content

Table 4 Effect of Piperonal on Plasma lipid profiles in normal and experimental obese rats

From: Antiobesity potential of Piperonal: promising modulation of body composition, lipid profiles and obesogenic marker expression in HFD-induced obese rats

Groups

TC (mg/dl)

TG (mg/dl)

HDL (mg/dl)

LDL (mg/dl)

VLDL (mg/dl)

Phospholipids (mg/dl)

Free fatty acids (mg/dl)

ND control

113.5Ā±11.4

130.6Ā±6.6

50.0Ā±3.1

50.8Ā±4.6

35.7Ā±2.2

85.7Ā±5.3

64.6Ā±5.1

HFD control

311.1Ā±20.2 a*

259.5Ā±8.5 a*

26.6Ā±2.9 a*

130.8Ā±5.9 a*

81.7Ā±4.1 a*

147.9Ā±5.7 a*

116.1Ā±4.6 a*

HFDā€‰+ā€‰Orlistat5mg/kg b.wt

142.6Ā±9.8 b*

136.6Ā±11.1 b*

46.8Ā±3.4 b*

55.8Ā±5.5 b*

41.6Ā±4.4 b*

100.3Ā±5.2 b*

71.2Ā±4.3 b*

HFD+ Piperonal 20Ā mg/kg b.wt

254.0Ā±9.8

214.0Ā±9.4

31.3Ā±2.4

118.8Ā±9.6

84.7Ā±3.7

135.3Ā±4.3

106.4Ā±5.2

HFD+ Piperonal 30Ā mg/kg b.wt

211.0Ā±8.2

188.5Ā±10.4

38.7Ā±2.1

94.7Ā±5.8

74.1Ā±4.6

113.2Ā±10.6

88.6Ā±7.6

HFD+ Piperonal 40Ā mg/kg b.wt

158.3Ā±9.8 b*

145.8Ā±10.1 b*

46.4Ā±5.1 b*

53.1Ā±5.3 b*

46.7Ā±4.7 b*

97.9Ā±5.3 b*

68.1Ā±5.1 b*

  1. Values are statistically significant at *pā€‰<ā€‰0.05
  2. aSignificantly different from normal control
  3. bSignificantly different from HFD control